FTC accuses drug middlemen of inflating insulin prices

The Federal Trade Commission is suing three of the largest pharmacy middlemen companies, accusing them of inflating insulin prices. Antonio Ciaccia, president of Axis Advisors, a consulting company for the prescription drug supply chain industry joins LiveNOW's Austin Westfall.